Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer
Quintanar, Teresa (Hospital General Universitario de Elche)
Font, Carme (Hospital Clínic i Provincial de Barcelona)
Gallardo, Enrique (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT))
Barba, Raquel (Hospital Universitario Rey Juan Carlos (Madrid))
Obispo, Berta (Hospital Universitario Infanta Leonor)
Díaz-Pedroche, Carmen (Hospital Universitario 12 de Octubre (Madrid))
Universitat Autònoma de Barcelona. Departament de Medicina

Date:	2020
Abstract:	Up to 20% of cancer patients will develop some manifestation of venous thromboembolic disease (VTD) during their clinical course. VTD greatly impacts morbidity, mortality, quality of life and pharmaceutical expenditure. In addition, both thrombotic relapse and major haemorrhages derived from VTD treatment are more likely in oncological patients. To make the decision to establish secondary thromboprophylaxis as an indefinite treatment in these patients, it is important to review all the risk factors involved, whether related to the disease, the patient or the prior thrombotic event. The objectives of this consensus of the Spanish Society of Internal Medicine (Sociedad Española de Medicina Interna -SEMI) and the Spanish Society of Medical Oncology (Sociedad Española de Oncología Médica -SEOM) are to establish recommendations that help assess the risk of recurrence of VTD and haemorrhagic risk in patients with cancer, as well as to analyse the evidence that exists on the currently available drugs, which will allow the establishment of a protocol for shared decision-making with the informed patient.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Anticoagulants ; Haemorrhage ; Low-molecular-weight heparin ; Neoplasms ; Vitamin K ; Venous thrombosis
Published in:	Clinical & translational oncology, Vol. 23 (september 2020) , p. 697-708, ISSN 1699-3055

DOI: 10.1007/s12094-020-02477-6
PMID: 32885400

12 p, 775.3 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Parc Taulí Research and Innovation Institute (I3PT
Articles > Research articles
Articles > Published articles